These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23016858)

  • 1. ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6.
    Dani N; Barbosa AJ; Del Rio A; Di Girolamo M
    Curr Pharm Des; 2013; 19(4):624-33. PubMed ID: 23016858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role of intracellular mono-ADP-ribosylation in cancer biology.
    Scarpa ES; Fabrizio G; Di Girolamo M
    FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mono-ADP-ribosylation of the G protein betagamma dimer is modulated by hormones and inhibited by Arf6.
    Dani N; Mayo E; Stilla A; Marchegiani A; Di Paola S; Corda D; Di Girolamo M
    J Biol Chem; 2011 Feb; 286(8):5995-6005. PubMed ID: 21148312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport.
    Abd Elmageed ZY; Naura AS; Errami Y; Zerfaoui M
    Cell Signal; 2012 Jan; 24(1):1-8. PubMed ID: 21840394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of nucleocytoplasmic transport by ADP-ribosylation: the emerging role of karyopherin-β1 mono-ADP-ribosylation by ARTD15.
    Di Girolamo M
    Curr Top Microbiol Immunol; 2015; 384():189-209. PubMed ID: 25037261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders.
    Grimaldi G; Catara G; Palazzo L; Corteggio A; Valente C; Corda D
    Biochem Pharmacol; 2019 Sep; 167():64-75. PubMed ID: 31102582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Promise of Proteomics for the Study of ADP-Ribosylation.
    Daniels CM; Ong SE; Leung AK
    Mol Cell; 2015 Jun; 58(6):911-24. PubMed ID: 26091340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADP-ribosyltransferases and poly ADP-ribosylation.
    Liu C; Yu X
    Curr Protein Pept Sci; 2015; 16(6):491-501. PubMed ID: 25938242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology.
    Morone B; Grimaldi G
    Expert Rev Mol Med; 2024 Aug; 26():e17. PubMed ID: 39189367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of PARP and protein poly-ADP-ribosylation process in regulation of cell functions].
    Drel' VR; Shymans'kyĭ IO; Sybirna NO; Velykyĭ MM
    Ukr Biokhim Zh (1999); 2011; 83(6):5-34. PubMed ID: 22364016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADP-Ribosylated Peptide Enrichment and Site Identification: The Phosphodiesterase-Based Method.
    Daniels CM; Ong SE; Leung AKL
    Methods Mol Biol; 2017; 1608():79-93. PubMed ID: 28695505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADP-ribosylation and intracellular traffic: an emerging role for PARP enzymes.
    Grimaldi G; Corda D
    Biochem Soc Trans; 2019 Feb; 47(1):357-370. PubMed ID: 30710058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
    Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
    Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases.
    Eckei L; Krieg S; Bütepage M; Lehmann A; Gross A; Lippok B; Grimm AR; Kümmerer BM; Rossetti G; Lüscher B; Verheugd P
    Sci Rep; 2017 Feb; 7():41746. PubMed ID: 28150709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular Mono-ADP-Ribosylation in Signaling and Disease.
    Bütepage M; Eckei L; Verheugd P; Lüscher B
    Cells; 2015 Sep; 4(4):569-95. PubMed ID: 26426055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD⁺-dependent enzymes at the endoplasmic reticulum.
    Di Girolamo M; Fabrizio G; Scarpa ES; Di Paola S
    Curr Top Med Chem; 2013; 13(23):3001-10. PubMed ID: 24171768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer.
    Zhen Y; Zhang Y; Yu Y
    Cell Rep; 2017 Nov; 21(8):2326-2337. PubMed ID: 29166620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADP-ribosylation of histones by ARTD1: an additional module of the histone code?
    Hottiger MO
    FEBS Lett; 2011 Jun; 585(11):1595-9. PubMed ID: 21420964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machineries regulating the activity of the small GTPase Arf6 in cancer cells are potential targets for developing innovative anti-cancer drugs.
    Yamauchi Y; Miura Y; Kanaho Y
    Adv Biol Regul; 2017 Jan; 63():115-121. PubMed ID: 27776975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of ADP-ribosylation.
    Schüler H; Ziegler M
    FEBS J; 2013 Aug; 280(15):3542. PubMed ID: 23763848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.